The Journal of Organic Chemistry
NOTE
afford 2f (97.4 mg, 0.34 mmol, 68%) as a sticky brown solid. IR (KBr):
3061, 1626, 1562, 133, 817, 750 cmꢀ1. 1H NMR (300 MHz, CDCl3):
δ = 5.26 (s, 2 H), 7.16 (d, J = 8.9 Hz, 1H), 7.36ꢀ7.42 (m, 1 H),
7.47ꢀ7.56 (m, 3 H), 7.61(d, J = 7.3 Hz, 1 H), 7.77ꢀ7.85 (m, 6 H).
13C NMR (75 MHz, CDCl3): δ = 65.2, 114.4, 117.7, 121.1, 124.4,
127.5, 127.7, 128.5, 128.9, 129.1, 129.4, 130.0, 130.1, 132.0, 133.4,
137.9,193.9. HRMS: calcd for C20H16O2 [M þ 1] 287.1072, found
287.1069.
for 15 h to afford 2l (52 mg, 0.23 mmol, 45%) as a yellow sticky liquid. IR
(KBr): 3286, 2968, 1658, 1632, 1489, 1238 cmꢀ1. 1H NMR (500 MHz,
CDCl3): δ = 0.98 (t, J = 7 Hz, 3 H), 1.66ꢀ1.74 (m, 2 H), 2.71 (t,
J = 7.5 Hz, 2 H), 5.0 (s, 2 H), 6.79 (d, J = 8.5 Hz, 1 H), 7.14(d, J = 2.5 Hz,
1 H), 7.18ꢀ7.22 (m, 1 H), 7.26 (s, 1 H). 13C NMR (125 MHz, CDCl3):
δ = 14.0, 18.1, 39.2, 64.8, 117.8, 126.6, 128.5, 131.6, 131.9, 154.2, 198.4.
HRMS: calcd for C22H17O2 [M þ 1] 237.0682, found 237.0676.
(4-Fluorophenyl)(8-methoxy-2H-chromen-3-yl)methanone 2g
(Table 2, Entry 7). Compound 1g (142 mg, 0.5 mmol) and anhydrous
FeCl3 (12 mg, 0.08 mmol) were treated in acetonitrile solvent as
described for the synthesis of 2a for 6 h to afford 2g (97 mg, 0.34
mmol, 68%) as a yellow solid. Mp: 82 °C. IR (KBr): 3462, 1624, 1597,
1482, 1345, 1267, 1227 cmꢀ1. 1H NMR (300 MHz, CDCl3): δ = 3.89
(s, 3 H), 5.18 (s, 2 H), 6.74 (d, J = 6.9 Hz, 1 H), 6.86ꢀ6.93 (m, 2 H), 7.08
(s, 1 H), 7.16 (t, J = 8.5 Hz, 2 H), 7.73ꢀ7.78 (m, 2 H). 13C NMR
(75 MHz, CDCl3): δ = 56.3, 65.8, 115.2, 115.6, 115.9, 121.4, 121.7, 129.9,
131.6, 131.8, 133.8, 136.9, 144.7, 148.3, 163.6, 167.0 (d, JCꢀF = 255 Hz),
192.7. HRMS: calcd for C17H14FO3 [M þ 1] 285.0927, found 285.0922.
(4-Bromophenyl)(6,8-dichloro-2H-chromen-3-yl)methanone 2h
(Table 2, Entry 8). Compound 1h (192 mg, 0.5 mmol) and anhydrous
FeCl3 (12 mg, 0.08 mmol) were treated in acetonitrile solvent as
described for the synthesis of 2a for 7 h to afford 2h (142.1 mg, 0.37
mmol, 74%) as a yellow solid. Mp: 102 °C. IR (KBr): 3449, 1686, 1627,
1581, 1337, 1213, 826 cmꢀ1. 1H NMR (300 MHz, CDCl3): δ = 5.23
(s, 2 H), 7.0 (d, J = 7.5, 2 H), 7.32 (brs, 1 H), 7.62 (dd, J = 8.3, 17.3 Hz,
4 H).13 13C NMR (125 MHz, CDCl3): δ = 66.2, 122.6, 123.0, 126.7,
127.2, 127.7, 130.7, 131.3, 132.1, 132.3, 134.6, 135.8, 150.0, 192.5.
HRMS: calcd for C16H10BrCl2O2 [M þ 1] 382.9241, found 382.9236.
(2H-Chromen-3-yl)(4-methoxyphenyl)methanone 2i (Table 2, Entry 9).
Compound 1i (133 mg, 0.5 mmol) and anhydrous FeCl3 (12 mg,
0.08 mmol) were treated in acetonitrile solvent as described for the
synthesis of 2a for 4 h to afford 2i (85 mg, 0.32 mmol, 64%) as a yellow
solid. Mp: 85 °C. IR (KBr): 3447, 1616, 1599, 1570, 1256, 1171,
751 cmꢀ1. 1H NMR (300 MHz, CDCl3) δ: 3.80 (s, 3 H), 5.05 (s, 2 H),
6.80ꢀ6.85 (m, 1 H), 6.89 (d, J = 5.0 Hz, 2 H), 6.90ꢀ7.0 (m, 2 H), 7.68
(dd, J = 6.9, 2.0 Hz, 2 H). 13C NMR (75 MHz, CDCl3) δ: 55.6, 65.7,
113.9, 116.5, 121.3, 121.9, 129.3, 130.1, 130.2, 131.5, 132.3, 135.8,
155.6, 163.1, 192.9. HRMS: calcd for C17H14NaO3 [M þ Na]
289.0841, found 289.0836.
’ ASSOCIATED CONTENT
S
Supporting Information. Copies of NMR spectra. This
b
acs.org.
’ AUTHOR INFORMATION
Corresponding Author
*Tel: þ9133-2414-6152, þ91-9051230927. Fax: þ91-33-2414-
6584. E-mail: jumasish2004@yahoo.co.in.
’ ACKNOWLEDGMENT
We acknowledge the financial and infrastructural support
from the UGC-CAS program of the Department of Chemistry,
Jadavpur University. The DST-PURSE program is also gratefully
acknowledged. K.B. and S.S. are thankful to the CSIR, New
Delhi, India, for their fellowships. S.M. and S.B. are also thankful
to the UGC, Jadavpur University, New Delhi, India, for their
fellowships.
’ REFERENCES
(1) (a) Ellis, G. P. Chromenes, chromanones, and chromones; Wiley-
Interscience: New York, 1977. (b) Hepworth, J. D. In Comprehensive
Heterocyclic Chemistry; Katritzky, A. R., Rees, C. W., Boulton, A. J.,
McKillop, A., Eds.; Pergamon Press: Oxford, 1984; Vol. 3, pp 737ꢀ883.
(c) For reviews on applications, see: Fravel, B. W.; Nedolya, N. A. In
Comprehensive Heterocyclic Chemistry III; Katritzky, A. R., Ramsden,
C. A., Scriven, E. F. V., Taylor, R. J. K., Eds.; Elsevier Ltd.: Oxford, 2008;
Vol. 7, pp 701ꢀ726 and previous editions of this series.
(2) (a) Engler, T. A.; LaTessa, K. O.; Iyengar, R.; Chai, W.; Agrios, K.
Bioorg. Med. Chem. 1996, 4, 1755–1769. (b) Kashiwada, Y.; Yamazaki,
K.; Ikeshiro, Y.; Yamagishi, T.; Fujioka, T.; Mihashi, K.; Mizuki, K.;
Cosentino, L. M.; Fowke, K.; Morris-Natschke, S. L.; Lee, K. H.
Tetrahedron 2001, 57, 1559–1563.
(3) Elomri, A.; Mitaku, S.; Michel, S.; Skaltsounis, A.-L.; Tillequin,
F.; Koch, M.; Pierre, A.; Guilbaud, N.; Lꢀeonce, S.; Kraus-Berthier, L.;
Rolland, Y.; Atassi, G. J. Med. Chem. 1996, 39, 4762–4766.
(4) (a) Kidwai, M.; Saxena, S.; Khan, M. K. R.; Thukral, S. S. Bioorg.
Med. Chem. Lett. 2005, 15, 4295–4298. (b) Tahtaoui, C.; Demailly, A.;
Guidemann, C.; Joyeux, C.; Schneider, P. J. Org. Chem. 2010, 75,
3781–3785.
(5) Lago, J. H. G.; Ramos, C. S.; Casanova, D. C. C.; Morandim, A.;
de, A.; Bergamo, D. C. B.; Cavalheiro, A. J.; Bolzani, V.; da, S.; Furlan, M.;
Guilhar~aes, E. F.; Young, M. C. M.; Kato, M. J. J. Nat. Prod. 2004, 67,
1783–1788.
(6) Bernard, C. B.; Krishnamurty, H. G.; Chauret, D.; Durst, T.;
Philogene, B. J. R.; Sanchez Vindas, P.; Hasbun, C.; Poveda, L.; San
Roman, L.; Arnason, J. T. J. Chem. Ecol. 1995, 21, 801–814.
(7) Mukai, K.; Okabe, K.; Hosose, H. J. Org. Chem. 1989, 54,
557–560.
Phenyl(6-phenyl-2H-chromen-3-yl)methanone 2j (Table 2, Entry
10). Compound 1j (156 mg, 0.5 mmol) and anhydrous FeCl3 (12 mg,
0.08 mmol) were treated in acetonitrile solvent as described for the
synthesis of 2a for 4 h to afford 2j (106 mg, 0.34 mmol, 68%) as a
greenish yellow solid. Mp: 102 °C. IR (KBr): 2360, 1625, 1337, 765,
1
711 cmꢀ1. H NMR (500 MHz, CDCl3): δ = 5.21 (s, 2 H), 7.0 (d,
J = 8.5 Hz, 1 H), 7.19 (s, 1 H), 7.31ꢀ7.35 (m, 2 H), 7.40 (t, J = 7.7 Hz,
2 H), 7.49ꢀ7.53 (m, 4 H), 7.58ꢀ7.61 (m, 2 H), 7.75 (d, J = 8.0 Hz, 2 H).
13C NMR (125 MHz, CDCl3): δ = 65.6, 116.9, 121.3, 126.8, 127.3,
128.0, 128.6, 129.0, 129.1, 129.5, 130.3, 131.3, 132.2, 137.1, 140.1, 155.2,
194.2. HRMS: calcd for C22H17O2 [M þ 1] 313.1229, found 313.1224.
1-(2H-Chromen-3-yl)ethanone 2k (Table 2, Entry 11). Compound
1k (87 mg, 0.5 mmol) and anhydrous FeCl3 (12 mg, 0.08 mmol) were
treated in 1,2-dichloroethane solvent as described for the synthesis of 2a
for 11 h to afford 2k (44 mg, 0.25 mmol, 50%) as a pale yellow solid. Mp:
86 °C. IR (KBr): 3298, 2924, 1654, 1604, 1458 cmꢀ1. 1H NMR (400 MHz,
CDCl3): δ = 2.34 (s, 3 H), 4.94 (s, 2H), 6.79 (d, J = 8.0 Hz, 1 H), 6.87
(t, J = 7.4 Hz, 1 H) 7.10 (d, J = 7.6 Hz, 1 H), 7.17ꢀ7.22 (m, 1 H), 7.24
(brs, 1 H). 13C NMR (100 MHz, CDCl3): δ = 24.0, 63.2, 115.3, 119.7,
120.8, 128.1, 129.7, 131.5, 133.0, 154.5, 195.0. HRMS: calcd for
C11H11O2 [M þ 1] 175.0759, found 175.0761.
(8) Jankun, J.; Selman, S. H.; Swiercz, R. Nature 1997, 387, 561.
(9) (a) Paramonov, S.; Delbaere, S.; Fedorova, O.; Fedorov, Y.;
Lokshin, V.; Samat, A.; Vermeersch, G. J. Photochem. Photobiol. A 2010,
209, 111. (b) Evans, R. A.; Such, G. K. Aust. J. Chem. 2005, 58, 825.
1-(2H-Chromen-3-yl)butan-1-one 2l (Table 2, Entry 12). Compound
1l (115 mg, 0.5 mmol) and anhydrous FeCl3 (12 mg, 0.08 mmol) were
treated in 1,2-dichloroethane solvent as described for the synthesis of 2a
3543
dx.doi.org/10.1021/jo2000012 |J. Org. Chem. 2011, 76, 3539–3544